Aktiesnakken — Juni 2020
-
Konsolidator signs first customer in Asia.
Konsolidator’s sales partner in Singapore and Malaysia, AP Flow Group, has signed its first customer in Singapore.
-
Hvis Konsolidator kan få fodfæste i Asien, står de foran markant vækst
-
Holger Zschaepitz
@Schuldensuehner
·
1 t
#Facebook shares plunge 7%, equal to $50bn of mkt cap, on Facebook ad boycotts. Brands like Ben & Jerry’s, Verizon and Unilever are pulling ad spending from Facebook, citing hate speech, racist content, and polarized politics as the key reasons for its decision. -
Reuters
@Reuters
·
36 min
U.S. consumer spending rebounds; falling income, surging COVID-19 cases loom https://reuters.com/article/us-usa-economy-spending-idUSKBN23X1QE?taid=5ef649461da48f00010f7a40&utm_campaign=trueAnthem%3A+Trending+Content&utm_medium=trueAnthem&utm_source=twitter -
God morgen.
-
Holger Zschaepitz
@Schuldensuehner
·
2 t
The future of #inflation is the biggest question in finance: The key debate on Wall Street is whether inflation is coming back with a vengeance. Inflation can wreck even the safest portfolio by eroding the value of investments for decades. https://bloomberg.com/news/articles/ -
Nikkei 225 i Tokyo er ned 1,32 prosent
Kospi i Seoul synker med 1,42 prosent
Hang Seng i Hongkong er ned 0,88
Singapore-børsen er ned 1,58 prosent
ASX 200 i Sydney ned 1,92 prosent
Shanghai-børsen synker med 0,72 prosent -
Holger Zschaepitz
@Schuldensuehner
·
8 t
Trump drops to a record low, while Biden marks a record high: Current PredictIt odds put Biden at 62% of winning US election in Nov from a low of 4% in Feb while Trump sits at 39% down from a high of 57% in Feb. -
Bloomberg Markets
@markets
·
4 t
Gold futures edged closer toward $1,800 an ounce -- a level last seen at the end of 2011 -- as demand for haven assets surged -
Deutsche Bank har løftet sit langsigtede kursmål for DSV Panalpina-aktien.
Kursmålet er løftet til 900 kr. fra 770 kr., fremgår det af data hos Bloomberg News.
Anbefalingen af aktien, der fredag steg 0,6 pct. til 791,80 kr., er fortsat "køb".
/ritzau/FINANS
-
Fedt.
-
Novo får japansk ja til Rybelsus mod type 2-diabetes - NY
07:23
De japanske myndigheder har godkendt Novo Nordisks middel Rybelsus til behandling af type 2-diatbetes blandt voksne.Det oplyser medicinalselskabet mandag morgen i en meddelelse til fondsbørsen.
-
Novo får japansk ja til Rybelsus mod type 2-diabetes - NY
07:23
De japanske myndigheder har godkendt Novo Nordisks middel Rybelsus til behandling af type 2-diatbetes blandt voksne.Det oplyser medicinalselskabet mandag morgen i en meddelelse til fondsbørsen.
Forskningsdirektør Mads Krogsgaard Thomsen er meget tilfreds med godkendelsen.
- At kunne tilbyde folk med type 2-diabetes effektiv og bekvemmelig behandlingsmuligheder er essentielt, da millioner af mennesker lige nu ikke når deres
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind